Financials data is unavailable for this security.
View more
Year on year MacroGenics Inc has grown net income from a loss of -119.76m to a smaller loss of -9.06m despite falling revenues.
Gross margin | 79.37% |
---|---|
Net profit margin | -332.47% |
Operating margin | -357.86% |
Return on assets | -53.82% |
---|---|
Return on equity | -118.91% |
Return on investment | -67.56% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at MacroGenics Inc fell by 7.93m. Cash Flow from Financing totalled 150.36m or 255.94% of revenues. In addition the company used 78.21m for operations while cash used for investing totalled 80.08m.
Cash flow per share | -2.07 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.9218 |
---|---|
Tangible book value per share | 0.9218 |
More ▼
Balance sheet in USDView more
Current ratio | 2.71 |
---|---|
Quick ratio | 2.69 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼